Table 1.
Study | Country | Duration between Infections | Immunological Comorbidities | Severity | |
---|---|---|---|---|---|
First Episode of Infection | Second Episode of Infection | ||||
[9] | Hong Kong | 142 days | No | Mild | Asymptomatic |
[10] | Qatar | 46 days | No | Mild/Asymptomatic | Mild/Asymptomatic |
[10] | Qatar | 71 days | No | Mild/Asymptomatic | Mild/Asymptomatic |
[10] | Qatar | 88 days | No | Mild/Asymptomatic | Mild/Asymptomatic |
[10] | Qatar | 55 days | No | Mild/Asymptomatic | Mild/Asymptomatic |
[12] | Belgium | 3 months | No | Mild | Mild |
[13] | USA | 42 days | No | Mild | Severe |
[14] | Netherlands | 59 days | Yes (Waldenström macroglobulinemia) |
Severe | Severe (death) |
[15] | Brazil | 52 days | No | Mild–Severe | Mild |
[16] | Brazil | 116 days | No | Mild | Mild |
[17] | Brazil | 147 days | No | Mild | Severe |